G9J-18021-64588
3 vaccinations
12 coded responses
36 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 452 / OH
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- FM6-10601-64984
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Registered in v-safe
-
2022-07-09
Dose 1 — Moderna
- 2022-07-09
-
2022-07-10
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-11
-
2022-07-12
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Exposure to SARS-CoV-2 — Feeling: Fair · Fever · Sleepiness, Vomiting · Be unable to do your normal daily activitiesFree text: (b)(6)'s dad was Covid positive on a RAT 7/11. Will get (b)(6) tested ASAPMedDRA releases: 2024-11 · check-in free text available
-
2022-07-13
Survey response — days 1–6 daily, dose 1, under 3MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to do your normal daily activitiesFree text: (b)(6) was Covid pos (on PCR) 7/12MedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Survey response — days 1–6 daily, dose 1, under 3MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Fever · Sleepiness · Be unable to do your normal daily activitiesFree text: Covid pcr pos 7/12MedDRA releases: 2024-11 · check-in free text available
-
2022-07-15
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Fever · Sleepiness · Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-07-16
- 2022-07-23
-
2022-07-30
Survey response — day 21, dose 1, under 3MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Tested positive for Covid 7/12/22MedDRA releases: 2024-11 · check-in free text available
- 2022-08-06
- 2022-08-22
-
2022-08-29
Dose 2 — Moderna
-
2022-08-31
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Medical counselling — Feeling: Fair · Sleepiness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Texted our pediatricianMedDRA releases: 2024-11 · check-in free text available
-
2022-08-31
Report sent to call center — days 1–6 daily, dose 2, under 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-09-01
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Vomiting, Diarrhea, Rash, not including the immediate area around the injection siteUnder 3 check-in
-
2022-09-01
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-02
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Sleepiness, Rash, not including the immediate area around the injection siteUnder 3 check-in
-
2022-09-03
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Body temperature increased — Feeling: Fair · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Tactile fever, but measured temp only 97.9MedDRA releases: 2024-11 · check-in free text available
-
2022-09-04
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Irritability, Teething — Feeling: Good · SleepinessFree text: Getting 4 molars. May likely explain some of the fussiness this past week.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-05
- 2022-09-12
-
2022-09-19
Survey response — day 21, dose 2, under 3MedDRA: SARS-CoV-2 test negative, Viral upper respiratory tract infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Viral URI. Home COVID RAT negMedDRA releases: 2024-11 · check-in free text available
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-11-30
-
2023-01-06
Dose 3 — Moderna
- 2023-01-07
- 2023-01-08
-
2023-01-09
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Frequent bowel movements — Feeling: GoodMedDRA releases: 2024-11
-
2023-01-11
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Unevaluable event — Feeling: GoodMedDRA releases: 2024-11
- 2023-01-12
- 2023-01-13
- 2023-01-20
- 2023-01-27
- 2023-02-03
- 2023-02-10
-
2023-02-17
Survey response — day 42, dose 3, under 3MedDRA: Viral upper respiratory tract infection — Feeling: GoodMedDRA releases: 2024-11
-
2023-04-07
Survey response — 3 months, dose 3, under 3MedDRA: Viral upper respiratory tract infection — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-09 | Moderna | No |
| 2 | 2022-08-29 | Moderna | No |
| 3 | 2023-01-06 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): (b)(6)'s dad was Covid positive on a RAT 7/11. Will get (b)(6) tested ASAP
redacted (b)(6)
Systemic reaction (other): Covid pcr pos 7/12
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Tested positive for Covid 7/12/22
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Healthcare visit (other): Texted our pediatrician
Systemic reaction (other): Tactile fever, but measured temp only 97.9
Systemic reaction (other): Getting 4 molars. May likely explain some of the fussiness this past week.
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Viral URI. Home COVID RAT neg
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
| SRO | Body temperature increased | · | · | ✓ |
| SRO | Exposure to SARS-CoV-2 | · | · | ✓ |
| SRO | Frequent bowel movements | · | · | ✓ |
| SRO | Irritability | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Teething | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release